Gene · 1059
Papers1,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CD44/POU2F2/BCL9L axis mediates MIF-driven SPP1+TAM activation in colorectal cancer metastasis. | Int J Biol Sci | 2026 | 41800265 | PubTator, text mining | PubMed |
| Non-Conventional and Emerging Autoantibodies in Sjögren's Disease. | J Inflamm Res | 2026 | 41798638 | PubTator, text mining | PubMed |
| Single-cell analysis of TIGD genes in hepatocellular carcinoma: Prognostic value and functional characterization. | Transl Oncol | 2026 | 41775084 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| Prevalence and clinical associations of anti-rods and rings antibodies in ANA-tested patients. | Immunol Res | 2026 | 41712038 | PubTator, text mining | PubMed |
| Association between autoantibodies and interstitial lung disease in autoimmune disease patients: a retrospective study. | Clin Exp Rheumatol | 2026 | 41678157 | PubTator, text mining | PubMed |
| Anti-CENP-B polarity divides SLE: divergent clinical-immune phenotypes and distinct treatment responses. | Front Immunol | 2026 | 41659860 | PubTator, text mining | PubMed |
| Forced vital capacity as a survival predictor in systemic sclerosis-associated pulmonary hypertension. | Ther Adv Musculoskelet Dis | 2026 | 41568288 | PubTator, text mining | PubMed |
| Synthetic rewriting technologies in mammalian cells. | Nat Commun | 2026 | 41530163 | PubTator, text mining | PubMed |
| Autoimmune diseases drive biological false-positive syphilis serology: A retrospective cohort of 35,995 tests. | Clin Chim Acta | 2026 | 41076102 | PubTator, text mining | PubMed |
| Longitudinal Autoantibody and Proteomic Signatures of Disease Progression in Systemic Sclerosis. | Arthritis Rheumatol | 2026 | 40928059 | PubTator, text mining | PubMed |
| Assessing the concordance between centromere AC-3 immunofluorescence pattern and anti-centromere protein-B antibody, and analyzing clinical correlates of dual positivity: A retrospective study. | Medicine (Baltimore) | 2025 | 41398805 | PubTator, text mining | PubMed |
| Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patients. | J Circ Biomark | 2025 | 41312416 | PubTator, text mining | PubMed |
| Systemic Sclerosis in Kazakh Patients: A Preliminary Case-Control Immunogenetic Profiling Study. | Pathophysiology | 2025 | 41283471 | PubTator, text mining | PubMed |
| Revisiting the question: When is a centromere not a kinetochore? | Chromosome Res | 2025 | 41137946 | PubTator, text mining | PubMed |
| Direct circMAN1A2(2,3,4,5)-CENPB mRNA interaction regulates cell proliferation and cancer progression. | Nat Commun | 2025 | 41022764 | PubTator, text mining | PubMed |
| Comparative single-cell and spatial profiling of anti-SSA-positive and anti-centromere-positive Sjögren's disease reveals common and distinct immune activation and fibroblast-mediated inflammation. | Nat Commun | 2025 | 40983612 | PubTator, text mining | PubMed |
| Evaluating the diagnostic efficacy of anti-M2-3E, anti-gp210, and anti-sp100 antibodies in primary biliary cirrhosis. | Lab Med | 2025 | 40973111 | PubTator, text mining | PubMed |
| CENP-A is diluted during bovine spermatogenesis and is maintained at internally positioned centromere clusters in mature bull sperm. | Chromosome Res | 2025 | 40958016 | PubTator, text mining | PubMed |
| An electrostatic repulsion model of centromere organisation. | bioRxiv | 2025 | 40950056 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1059/papers?page=2